The company said the treatment had cut the risk of symptomatic Covid in patients with conditions that put them at high risk, or who had not responded well to a vaccine.
USA: AstraZeneca Seeks F.D.A. Approval for Covid Antibody Treatment
Reviewed by Shahid Karimi
on
October 05, 2021
Rating:
No comments: